Orebro Musculoskeletal Screening Questionnaire-12
- Conditions
- Musculoskeletal Injury
- Registration Number
- NCT04723615
- Lead Sponsor
- Afyonkarahisar Health Sciences University
- Brief Summary
The research is a study with methodological design. The validity, reliability and practicality of the Örebro Musculoskeletal System Screening Questionnaire-12 will be investigated. In this context, a questionnaire will be applied to the participants to take part in the study after the translation process is completed.
- Detailed Description
Musculoskeletal disorders are quite common in developed and developing countries. Musculoskeletal disorders cause economic burdens in the individual and social field. In addition, getting reports is one of the main causes of reduced productivity and work disability. Therefore, inexpensive and easily applicable screening questionnaires are needed to determine the patient population with high risk musculoskeletal disorders. The Örebro Musculoskeletal Screening Questionnaire is a practical questionnaire that can evaluate musculoskeletal disorders and is tailored to the WHO-ICF themes. For this reason, the aim of the study is to translate the Örebro Musculoskeletal System Survey-12 into Turkish intercultural translation and to investigate the construct validity, reliability and practicality.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 319
- Having any musculoskeletal problems (spine, upper or lower extremities)
- Being in the age range of 18-65
- Pregnancy
- Having of red flag signs.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Orebro Musculoskeletal Screening Questionnaire-12 10 minutes It is a 12-item self-report questionnaire that aims to estimate a wide range of outcomes (severity of the problem, functional impairment, reporting status, cost and recovery time) in patients with acute and subacute work injury presenting with musculoskeletal pain involving the spine, upper and lower extremities.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Emel Taşvuran Horata
🇹🇷Afyonkarahisar, Turkey